Medlogix srl

Medlogix designs, manufactures, and sells innovative hyperthermia systems for oncology, physiotherapy, and sports medicine. Medlogix began its activities in 2009 with the sale of the ALBA ON 4000 device for superficial hyperthermia.

From 2010 onwards Medlogix has started a series of technical and scientific collaborations with several excellent university centers, such as the University of Tor Vergata (Rome, Italy), the AMC/University of Amsterdam (Amsterdam, Netherlands), ErasmusMC (Rotterdam, Netherlands), the Czech Technical University (Prague, Czech Republic), for the development of innovative and technically advanced customized projects in the field of oncological hyperthermia.

From the collaborations with these academic institutions, Medlogix Srl has managed to develop and market the most advanced hyperthermia products for the radiation oncology field.